Cargando…
Network-based characterization of drug-protein interaction signatures with a space-efficient approach
BACKGROUND: Characterization of drug-protein interaction networks with biological features has recently become challenging in recent pharmaceutical science toward a better understanding of polypharmacology. RESULTS: We present a novel method for systematic analyses of the underlying features charact...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6449886/ https://www.ncbi.nlm.nih.gov/pubmed/30953486 http://dx.doi.org/10.1186/s12918-019-0691-1 |
_version_ | 1783408942218477568 |
---|---|
author | Tabei, Yasuo Kotera, Masaaki Sawada, Ryusuke Yamanishi, Yoshihiro |
author_facet | Tabei, Yasuo Kotera, Masaaki Sawada, Ryusuke Yamanishi, Yoshihiro |
author_sort | Tabei, Yasuo |
collection | PubMed |
description | BACKGROUND: Characterization of drug-protein interaction networks with biological features has recently become challenging in recent pharmaceutical science toward a better understanding of polypharmacology. RESULTS: We present a novel method for systematic analyses of the underlying features characteristic of drug-protein interaction networks, which we call “drug-protein interaction signatures” from the integration of large-scale heterogeneous data of drugs and proteins. We develop a new efficient algorithm for extracting informative drug-protein interaction signatures from the integration of large-scale heterogeneous data of drugs and proteins, which is made possible by space-efficient representations for fingerprints of drug-protein pairs and sparsity-induced classifiers. CONCLUSIONS: Our method infers a set of drug-protein interaction signatures consisting of the associations between drug chemical substructures, adverse drug reactions, protein domains, biological pathways, and pathway modules. We argue the these signatures are biologically meaningful and useful for predicting unknown drug-protein interactions and are expected to contribute to rational drug design. |
format | Online Article Text |
id | pubmed-6449886 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-64498862019-04-15 Network-based characterization of drug-protein interaction signatures with a space-efficient approach Tabei, Yasuo Kotera, Masaaki Sawada, Ryusuke Yamanishi, Yoshihiro BMC Syst Biol Research BACKGROUND: Characterization of drug-protein interaction networks with biological features has recently become challenging in recent pharmaceutical science toward a better understanding of polypharmacology. RESULTS: We present a novel method for systematic analyses of the underlying features characteristic of drug-protein interaction networks, which we call “drug-protein interaction signatures” from the integration of large-scale heterogeneous data of drugs and proteins. We develop a new efficient algorithm for extracting informative drug-protein interaction signatures from the integration of large-scale heterogeneous data of drugs and proteins, which is made possible by space-efficient representations for fingerprints of drug-protein pairs and sparsity-induced classifiers. CONCLUSIONS: Our method infers a set of drug-protein interaction signatures consisting of the associations between drug chemical substructures, adverse drug reactions, protein domains, biological pathways, and pathway modules. We argue the these signatures are biologically meaningful and useful for predicting unknown drug-protein interactions and are expected to contribute to rational drug design. BioMed Central 2019-04-05 /pmc/articles/PMC6449886/ /pubmed/30953486 http://dx.doi.org/10.1186/s12918-019-0691-1 Text en © The Author(s) 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Tabei, Yasuo Kotera, Masaaki Sawada, Ryusuke Yamanishi, Yoshihiro Network-based characterization of drug-protein interaction signatures with a space-efficient approach |
title | Network-based characterization of drug-protein interaction signatures with a space-efficient approach |
title_full | Network-based characterization of drug-protein interaction signatures with a space-efficient approach |
title_fullStr | Network-based characterization of drug-protein interaction signatures with a space-efficient approach |
title_full_unstemmed | Network-based characterization of drug-protein interaction signatures with a space-efficient approach |
title_short | Network-based characterization of drug-protein interaction signatures with a space-efficient approach |
title_sort | network-based characterization of drug-protein interaction signatures with a space-efficient approach |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6449886/ https://www.ncbi.nlm.nih.gov/pubmed/30953486 http://dx.doi.org/10.1186/s12918-019-0691-1 |
work_keys_str_mv | AT tabeiyasuo networkbasedcharacterizationofdrugproteininteractionsignatureswithaspaceefficientapproach AT koteramasaaki networkbasedcharacterizationofdrugproteininteractionsignatureswithaspaceefficientapproach AT sawadaryusuke networkbasedcharacterizationofdrugproteininteractionsignatureswithaspaceefficientapproach AT yamanishiyoshihiro networkbasedcharacterizationofdrugproteininteractionsignatureswithaspaceefficientapproach |